Apimeds Pharmaceuticals US, Inc (APUS) Technical Analysis & Indicators

Apimeds Pharmaceuticals US, Inc (APUS) — Price $1.60 HealthcareBiotechnology — AMEX

Latest reported results:

Technical analysis of Apimeds Pharmaceuticals US, Inc (APUS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Price Performance

1 month-60.00%
3 months-85.32%
Year-to-date-90.24%
1 year-91.06%

52-Week Range

52-week High$59.70
52-week Low$1.51
Avg Volume (90d)91K

Technical Indicators

SMA 50$4.76
SMA 200$13.33
Beta-1.37
30-day Volatility (annualised)133.9%
Price vs SMA 50-66.4%
Price vs SMA 200-88.0%

Monthly Close (12 months)

MonthCloseChange
2025-10$21.90
2025-11$29.00+32.4%
2025-12$16.40-43.4%
2026-01$18.50+12.8%
2026-02$13.60-26.5%
2026-03$17.90+31.6%
2026-04$18.80+5.0%
2026-05$14.10-25.0%
2026-06$9.00-36.2%
2026-07$5.15-42.8%
2026-08$3.88-24.7%
2026-09$1.60-58.8%

Price

Price$1.60
Market Cap$2M
ExchangeAMEX
CountryUS

Valuation Ratios

Price / Book0.02
EV / EBITDA-0.33
Dividend Yield0.00%

Financial Health

Debt / Equity0.14
Current Ratio0.51

Related companies: ANTX · IGC · MIRA · MLSS · MYO · NXTC · POCI

Explore sector: Healthcare · Biotechnology

More sections of APUS: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks